What is Platysma Botox and Why is it Having a Moment

For years, injectable conversations were dominated by the upper face. Forehead lines, frown lines and crow’s feet were the familiar entry points, while the neck was often treated as a separate problem, something to be addressed later, or surgically. Platysma Botox is moving into the mainstream of aesthetic practice as patients increasingly focus on the neck as a visible marker of ageing and seek treatment options that can soften early changes without surgery and changing the market. The treatment itself is not new, but its profile is rising as awareness grows, clinical protocols become more refined and the industry’s attention shifts towards lower-face and neck rejuvenation.

At its simplest, platysma Botox involves injecting botulinum toxin into the platysma, the thin superficial muscle that runs from the upper chest into the lower face and jawline. As this muscle becomes more active or more visible with age, it can contribute to the appearance of vertical neck bands and a less defined jawline. Relaxing selected parts of the muscle can soften those bands and reduce some of the downward pull on the lower face, leading to a smoother neck and cleaner mandibular contour in appropriate patients.

That appeal is reflected in clinic demand, as Dr Ash Soni, UK & US trained Plastic Surgeon based at The Langham says, “Platysma Botox is certainly gaining in popularity in my clinic. I think more patients are becoming aware that this is a possibility to release the neck bands, and also the neck has become an area that patients are focusing on now. Over the years, the neck was an area that was neglected, but now it’s something that patients are actively addressing.” Neuromodulators remain one of the most widely performed non-surgical procedures, with the American Society of Plastic Surgeons reporting a 4% rise in neuromodulator injections in 2024, while ISAPS recorded 7.8 million botulinum toxin procedures globally. As confidence in toxin has grown, patients have become more comfortable extending treatment beyond the upper face.

Regulatory approval has also helped bring the treatment into sharper focus. In October 2024, BOTOX Cosmetic became the first aesthetic neurotoxin approved by the FDA for moderate to severe platysma bands, giving formal recognition to an indication that had already been used in practice for some time. That matters because FDA approval does more than validate a treatment in one market. It raises awareness, prompts education, sharpens patient demand and gives clinics a clearer framework for discussing outcomes.

The clinical evidence has strengthened at the same time. Phase 3 data published in Aesthetic Surgery Journal in 2025 found that onabotulinumtoxinA was effective and well tolerated for moderate to severe platysma prominence. By Day 14, 79.9% of treated patients achieved at least a 1-grade improvement compared with 21.8% in the placebo group, while 40.8% achieved at least a 2-grade improvement compared with 3.9% for placebo. Participants also reported improvements in satisfaction and a reduction in how bothered they felt by the appearance of their neck and jawline.

The important question is not just whether platysma Botox works, but what it works for. It is best understood as a treatment for muscular banding and downward pull, not as a universal answer to every sign of neck ageing. Reviews note that it can improve vertical neck bands and jawline definition, but does not substantially correct skin laxity or heavy submental fullness on its own. In other words, it can be highly useful for the right patient, but it does not replace treatments aimed at skin quality, collagen support or surgical lifting where tissue descent is more advanced.

Dr Yannis Alexandrides, triple board-certified Plastic Surgeon and Founder and Medical Director of 111 Harley St., comments. “As a Plastic & Reconstructive Surgeon specialising in face and neck lifts, I am regularly asked about non-surgical alternatives. Whilst there are many advanced non-surgical treatments and techniques, none will achieve the same result as a surgical procedure, however there are options that can provide improvements to the face and neck, especially for the earlier signs of ageing.” It is a useful distinction, particularly in a market where patient expectations are often shaped by short-form content and before-and-after imagery rather than anatomy.

Dr Alexandrides adds that, “with regards to the neck, and specifically, the vertical lines that can appear with age, Botox can be an option depending on the patient's goals and their suitability. The injectable can be used to temporarily relax the muscles in that area, soften the appearance of the lines, giving greater definition to the neck contour.” That is the sweet spot for platysma Botox: patients with visible banding, relatively mild to moderate changes and a desire for a subtle, lower-downtime intervention rather than surgery. He notes that the treatment “needs to be repeated approximately every 4-6 months” and says that at 111 Harley St. “this is a treatment that we see a demand for, and it can be highly effective for the right patient.”

A 2025 review on platysma prominence notes that ideal candidates tend to have prominent platysmal banding, some loss of jawline definition, and limited excess skin or submental fat. Once significant laxity, skin creping or volume-related changes become part of the picture, treatment often needs to broaden. This is one reason platysma Botox is increasingly discussed not as a standalone trend, but as part of a layered treatment plan.

That more integrated approach is also reflected in practice. Dr Soni notes that “platysmal Botox can often be combined with various regenerative biostimulators to improve the quality and appearance of the neck.” Dr Alexandrides makes a similar point from a surgical and device-led perspective, saying, “Myself and my team always take the time to carefully assess the patient's goals and the best options for them individually. In some cases, we may combine device-led treatments with anti-wrinkle injections in the same treatment plan. Using a device such as UltraClear, allows us to address texture, lines and wrinkles in addition to sun damage. This then lays an improved foundation to utilise Botox injections to soften the lines improving the overall result.” A growing trend to addressing concerns these days is to avoid isolated fixes and work towards combination protocols that address muscle activity, skin quality and structural ageing together.

The boom in platysma Botox also says something about how the aesthetics market is evolving. Patients are increasingly looking for refinement and the neck has become a more visible priority in that conversation. High-definition photography, video calls and the continued popularity of lower-face contouring have all played a role in drawing attention to an area that was once easier to overlook. The patient demand appears to be for a continuity between the face, jawline and neck. Platysma Botox fits neatly into that demand because it offers a relatively quick, familiar injectable route to a smoother transition between those zones.